Institutional shares held 160 Million
2.8M calls
1.42M puts
Total value of holdings $29.5B
$516M calls
$261M puts
Market Cap $34.2B
185,740,000 Shares Out.
Institutional ownership 86.18%
# of Institutions 1,118


Latest Institutional Activity in IQV

Top Purchases

Q2 2025
Norges Bank Shares Held: 1.71M ($316M)
Q2 2025
Aqr Capital Management LLC Shares Held: 1.56M ($286M)
Q2 2025
Laurel Wealth Advisors LLC Shares Held: 780K ($144M)
Q2 2025
Alyeska Investment Group, L.P. Shares Held: 746K ($137M)
Q2 2025
Squarepoint Ops LLC Shares Held: 827K ($152M)

Top Sells

Q2 2025
Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Shares Held: 325K ($59.8M)
Q2 2025
Pitcairn CO Shares Held: 2.25K ($415K)
Q2 2025
Morgan Stanley Shares Held: 2.4M ($441M)
Q2 2025
D. E. Shaw & Co., Inc. Shares Held: 437K ($80.4M)
Q2 2025
Cantillon Capital Management LLC Shares Held: 1.51M ($279M)

About IQV

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.


Insider Transactions at IQV

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
94.3K Shares
From 12 Insiders
Grant, award, or other acquisition 41.2K shares
Exercise of conversion of derivative security 51.9K shares
Open market or private purchase 1.28K shares
Sell / Disposition
59.7K Shares
From 10 Insiders
Sale (or disposition) back to the issuer 32.7K shares
Payment of exercise price or tax liability 19.4K shares
Open market or private sale 7.65K shares

Track Institutional and Insider Activities on IQV

Follow IQVIA HOLDINGS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IQV shares.

Notify only if

Insider Trading

Get notified when an Iqvia Holdings Inc. insider buys or sells IQV shares.

Notify only if

News

Receive news related to IQVIA HOLDINGS INC.

Track Activities on IQV